HemaSphere (Apr 2024)
Ponalfil trial for adults with Philadelphia chromosome‐positive acute lymphoblastic leukemia: Long‐term results
- Josep‐Maria Ribera,
- Mireia Morgades,
- Jordi Ribera,
- Pau Montesinos,
- Isabel Cano‐Ferri,
- Pilar Martínez,
- Jordi Esteve,
- Daniel Esteban,
- María García‐Fortes,
- Natalia Alonso,
- José González‐Campos,
- Arancha Bermúdez,
- Anna Torrent,
- Eulàlia Genescà,
- Clara Maluquer,
- Joaquín Martínez‐López,
- Ramón García‐Sanz
Affiliations
- Josep‐Maria Ribera
- Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain
- Mireia Morgades
- Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain
- Jordi Ribera
- Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain
- Pau Montesinos
- Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain
- Isabel Cano‐Ferri
- Department of Hematology Hospital Universitari i Politècnic La Fe Valencia Spain
- Pilar Martínez
- Department of Hematology Hospital Doce de Octubre Madrid Spain
- Jordi Esteve
- Department of Hematology Hospital Clínic Barcelona Spain
- Daniel Esteban
- Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain
- María García‐Fortes
- Department of Hematology Hospital Universitario Virgen de la Victoria Málaga Spain
- Natalia Alonso
- Department of Hematology Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain
- José González‐Campos
- Department of Hematology Hospital Universitario Virgen del Rocío. Instituto de Biomedicina de Sevilla (IBIS)/CSIC/CIBERONC. Universidad de Sevilla Sevilla Spain
- Arancha Bermúdez
- Department of Hematology Hospital Universitario Marqués de Valdecilla Santander Spain
- Anna Torrent
- Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain
- Eulàlia Genescà
- Department of Hematology, ICO‐Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute (IJC), Institut Germans Trias i Pujol (IGTP) Universitat Autònoma de Barcelona Badalona Spain
- Clara Maluquer
- Department of Hematology, ICO‐Hospital Duran i Reynals Hospitalet de Llobregat Spain
- Joaquín Martínez‐López
- Department of Hematology Hospital Doce de Octubre Madrid Spain
- Ramón García‐Sanz
- Department of Hematology, Hospital Universitario de Salamanca (HUS/IBSAL) CIBERONC and Center for Cancer Research‐IBMCC (USAL‐CSIC) Salamanca Spain
- DOI
- https://doi.org/10.1002/hem3.67
- Journal volume & issue
-
Vol. 8,
no. 4
pp. n/a – n/a
Abstract
No abstracts available.